HEADER OXIDOREDUCTASE/INHIBITOR 18-JUL-17 5WHR TITLE DISCOVERY OF A NOVEL AND SELECTIVE IDO-1 INHIBITOR PF-06840003 AND ITS TITLE 2 CHARACTERIZATION AS A POTENTIAL CLINICAL CANDIDATE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDOLEAMINE 2,3-DIOXYGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: IDO-1,INDOLEAMINE-PYRROLE 2,3-DIOXYGENASE; COMPND 5 EC: 1.13.11.52; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IDO1, IDO, INDO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS CANCER IMMUNOTHERAPY, SMALL MOLECULE INHIBITOR, OXIDOREDUCTASE, KEYWDS 2 OXIDOREDUCTASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,S.E.KAISER,J.L.FENG,A.STEWART REVDAT 2 09-OCT-24 5WHR 1 REMARK REVDAT 1 27-DEC-17 5WHR 0 JRNL AUTH S.CROSIGNANI,P.BINGHAM,P.BOTTEMANNE,H.CANNELLE, JRNL AUTH 2 S.CAUWENBERGHS,M.CORDONNIER,D.DALVIE,F.DEROOSE,J.L.FENG, JRNL AUTH 3 B.GOMES,S.GREASLEY,S.E.KAISER,M.KRAUS,M.NEGRERIE,K.MAEGLEY, JRNL AUTH 4 N.MILLER,B.W.MURRAY,M.SCHNEIDER,J.SOLOWEIJ,A.E.STEWART, JRNL AUTH 5 J.TUMANG,V.R.TORTI,B.VAN DEN EYNDE,M.WYTHES JRNL TITL DISCOVERY OF A NOVEL AND SELECTIVE INDOLEAMINE JRNL TITL 2 2,3-DIOXYGENASE (IDO-1) INHIBITOR JRNL TITL 3 3-(5-FLUORO-1H-INDOL-3-YL)PYRROLIDINE-2,5-DIONE JRNL TITL 4 (EOS200271/PF-06840003) AND ITS CHARACTERIZATION AS A JRNL TITL 5 POTENTIAL CLINICAL CANDIDATE. JRNL REF J. MED. CHEM. V. 60 9617 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 29111717 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00974 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 47663 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.740 REMARK 3 FREE R VALUE TEST SET COUNT : 2257 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3457 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2291 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3297 REMARK 3 BIN R VALUE (WORKING SET) : 0.2273 REMARK 3 BIN FREE R VALUE : 0.2659 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.63 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 160 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5870 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 269 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.80530 REMARK 3 B22 (A**2) : -6.09190 REMARK 3 B33 (A**2) : -8.71340 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.243 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.187 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.240 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.188 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6163 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8401 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2073 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 141 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 951 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6163 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 761 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7213 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.08 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.78 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.43 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WHR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1000229039. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 98 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : ACCEL DCM REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47881 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 131.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05700 REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.41800 REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HAMPTON RESEARCH PEG/ION SCREEN REMARK 280 CONDITION #4 (20% PEG3350, 0.2M LITHIUM CHLORIDE), VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.60000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.56000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.99500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.56000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.60000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.99500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 11 REMARK 465 SER A 12 REMARK 465 LYS A 13 REMARK 465 PRO A 362 REMARK 465 LYS A 363 REMARK 465 GLU A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 THR A 367 REMARK 465 SER A 368 REMARK 465 GLU A 369 REMARK 465 ASP A 370 REMARK 465 PRO A 371 REMARK 465 SER A 372 REMARK 465 LYS A 373 REMARK 465 LEU A 374 REMARK 465 GLU A 375 REMARK 465 GLY A 403 REMARK 465 GLY B 11 REMARK 465 GLN B 361 REMARK 465 PRO B 362 REMARK 465 LYS B 363 REMARK 465 GLU B 364 REMARK 465 ASN B 365 REMARK 465 LYS B 366 REMARK 465 THR B 367 REMARK 465 SER B 368 REMARK 465 GLU B 369 REMARK 465 ASP B 370 REMARK 465 PRO B 371 REMARK 465 SER B 372 REMARK 465 LYS B 373 REMARK 465 LEU B 374 REMARK 465 GLU B 375 REMARK 465 ALA B 376 REMARK 465 GLU B 402 REMARK 465 GLY B 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 101 CD CE NZ REMARK 470 LYS A 116 CE NZ REMARK 470 LYS A 117 CD CE NZ REMARK 470 LYS A 135 CE NZ REMARK 470 LYS A 198 CE NZ REMARK 470 LYS A 224 CE NZ REMARK 470 LYS A 337 CE NZ REMARK 470 LYS A 389 CD CE NZ REMARK 470 LYS A 401 CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 470 LYS B 44 CE NZ REMARK 470 GLU B 57 CG CD OE1 OE2 REMARK 470 LYS B 61 CD CE NZ REMARK 470 LYS B 101 CD CE NZ REMARK 470 LYS B 116 CE NZ REMARK 470 LYS B 117 CD CE NZ REMARK 470 LYS B 135 CE NZ REMARK 470 LYS B 141 NZ REMARK 470 LYS B 186 CG CD CE NZ REMARK 470 LYS B 209 CD CE NZ REMARK 470 LYS B 224 CE NZ REMARK 470 GLU B 254 CG CD OE1 OE2 REMARK 470 LYS B 337 CE NZ REMARK 470 LYS B 401 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 27 77.58 29.84 REMARK 500 ASP A 34 -26.50 -37.61 REMARK 500 ASN A 133 57.08 -101.75 REMARK 500 VAL A 229 -72.78 -121.43 REMARK 500 TRP A 237 57.66 -119.82 REMARK 500 LEU A 243 59.00 -141.71 REMARK 500 GLU A 250 122.99 -31.58 REMARK 500 ILE A 354 -57.70 -125.63 REMARK 500 GLN A 360 40.13 -90.46 REMARK 500 LEU A 384 -79.41 -13.84 REMARK 500 MET B 64 93.22 -53.78 REMARK 500 THR B 71 -60.71 -92.43 REMARK 500 ASP B 128 -65.69 -91.38 REMARK 500 VAL B 130 -58.58 -120.89 REMARK 500 ASN B 133 51.46 -106.16 REMARK 500 VAL B 229 -72.20 -125.92 REMARK 500 LEU B 384 -91.83 58.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 346 NE2 REMARK 620 2 HEM A 501 NA 92.8 REMARK 620 3 HEM A 501 NB 97.7 90.3 REMARK 620 4 HEM A 501 NC 102.9 164.3 87.8 REMARK 620 5 HEM A 501 ND 92.5 88.0 169.7 91.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 346 NE2 REMARK 620 2 HEM B 501 NA 97.4 REMARK 620 3 HEM B 501 NB 95.5 91.1 REMARK 620 4 HEM B 501 NC 94.8 167.7 89.6 REMARK 620 5 HEM B 501 ND 89.3 89.1 175.2 89.2 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AOJ A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AOJ B 502 DBREF 5WHR A 12 403 UNP P14902 I23O1_HUMAN 12 403 DBREF 5WHR B 12 403 UNP P14902 I23O1_HUMAN 12 403 SEQADV 5WHR GLY A 11 UNP P14902 EXPRESSION TAG SEQADV 5WHR GLY B 11 UNP P14902 EXPRESSION TAG SEQRES 1 A 393 GLY SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE SEQRES 2 A 393 ALA LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR SEQRES 3 A 393 ASN ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU SEQRES 4 A 393 ILE GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU SEQRES 5 A 393 ASN MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER SEQRES 6 A 393 GLN ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET SEQRES 7 A 393 ALA TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS SEQRES 8 A 393 VAL LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SEQRES 9 A 393 SER LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA SEQRES 10 A 393 ASP CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN SEQRES 11 A 393 LYS PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER SEQRES 12 A 393 PHE ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SEQRES 13 A 393 SER LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS SEQRES 14 A 393 VAL ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU SEQRES 15 A 393 ARG ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER SEQRES 16 A 393 CYS LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS SEQRES 17 A 393 ASP HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG SEQRES 18 A 393 ILE TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER SEQRES 19 A 393 ASP GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS SEQRES 20 A 393 GLU PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE SEQRES 21 A 393 GLN CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA SEQRES 22 A 393 GLY GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG SEQRES 23 A 393 ARG TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER SEQRES 24 A 393 LEU GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER SEQRES 25 A 393 LYS GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS SEQRES 26 A 393 VAL LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN SEQRES 27 A 393 ILE VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN SEQRES 28 A 393 PRO LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU SEQRES 29 A 393 GLU ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE SEQRES 30 A 393 LEU LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU SEQRES 31 A 393 LYS GLU GLY SEQRES 1 B 393 GLY SER LYS GLU TYR HIS ILE ASP GLU GLU VAL GLY PHE SEQRES 2 B 393 ALA LEU PRO ASN PRO GLN GLU ASN LEU PRO ASP PHE TYR SEQRES 3 B 393 ASN ASP TRP MET PHE ILE ALA LYS HIS LEU PRO ASP LEU SEQRES 4 B 393 ILE GLU SER GLY GLN LEU ARG GLU ARG VAL GLU LYS LEU SEQRES 5 B 393 ASN MET LEU SER ILE ASP HIS LEU THR ASP HIS LYS SER SEQRES 6 B 393 GLN ARG LEU ALA ARG LEU VAL LEU GLY CYS ILE THR MET SEQRES 7 B 393 ALA TYR VAL TRP GLY LYS GLY HIS GLY ASP VAL ARG LYS SEQRES 8 B 393 VAL LEU PRO ARG ASN ILE ALA VAL PRO TYR CYS GLN LEU SEQRES 9 B 393 SER LYS LYS LEU GLU LEU PRO PRO ILE LEU VAL TYR ALA SEQRES 10 B 393 ASP CYS VAL LEU ALA ASN TRP LYS LYS LYS ASP PRO ASN SEQRES 11 B 393 LYS PRO LEU THR TYR GLU ASN MET ASP VAL LEU PHE SER SEQRES 12 B 393 PHE ARG ASP GLY ASP CYS SER LYS GLY PHE PHE LEU VAL SEQRES 13 B 393 SER LEU LEU VAL GLU ILE ALA ALA ALA SER ALA ILE LYS SEQRES 14 B 393 VAL ILE PRO THR VAL PHE LYS ALA MET GLN MET GLN GLU SEQRES 15 B 393 ARG ASP THR LEU LEU LYS ALA LEU LEU GLU ILE ALA SER SEQRES 16 B 393 CYS LEU GLU LYS ALA LEU GLN VAL PHE HIS GLN ILE HIS SEQRES 17 B 393 ASP HIS VAL ASN PRO LYS ALA PHE PHE SER VAL LEU ARG SEQRES 18 B 393 ILE TYR LEU SER GLY TRP LYS GLY ASN PRO GLN LEU SER SEQRES 19 B 393 ASP GLY LEU VAL TYR GLU GLY PHE TRP GLU ASP PRO LYS SEQRES 20 B 393 GLU PHE ALA GLY GLY SER ALA GLY GLN SER SER VAL PHE SEQRES 21 B 393 GLN CYS PHE ASP VAL LEU LEU GLY ILE GLN GLN THR ALA SEQRES 22 B 393 GLY GLY GLY HIS ALA ALA GLN PHE LEU GLN ASP MET ARG SEQRES 23 B 393 ARG TYR MET PRO PRO ALA HIS ARG ASN PHE LEU CYS SER SEQRES 24 B 393 LEU GLU SER ASN PRO SER VAL ARG GLU PHE VAL LEU SER SEQRES 25 B 393 LYS GLY ASP ALA GLY LEU ARG GLU ALA TYR ASP ALA CYS SEQRES 26 B 393 VAL LYS ALA LEU VAL SER LEU ARG SER TYR HIS LEU GLN SEQRES 27 B 393 ILE VAL THR LYS TYR ILE LEU ILE PRO ALA SER GLN GLN SEQRES 28 B 393 PRO LYS GLU ASN LYS THR SER GLU ASP PRO SER LYS LEU SEQRES 29 B 393 GLU ALA LYS GLY THR GLY GLY THR ASP LEU MET ASN PHE SEQRES 30 B 393 LEU LYS THR VAL ARG SER THR THR GLU LYS SER LEU LEU SEQRES 31 B 393 LYS GLU GLY HET HEM A 501 43 HET AOJ A 502 26 HET HEM B 501 43 HET AOJ B 502 26 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM AOJ (3R)-3-(5-FLUORO-1H-INDOL-3-YL)PYRROLIDINE-2,5-DIONE HETSYN HEM HEME FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 AOJ 2(C12 H9 F N2 O2) FORMUL 7 HOH *269(H2 O) HELIX 1 AA1 PRO A 33 PHE A 35 5 3 HELIX 2 AA2 TYR A 36 HIS A 45 1 10 HELIX 3 AA3 HIS A 45 SER A 52 1 8 HELIX 4 AA4 GLN A 54 LYS A 61 1 8 HELIX 5 AA5 ASP A 72 GLY A 93 1 22 HELIX 6 AA6 PRO A 104 LEU A 118 1 15 HELIX 7 AA7 VAL A 125 VAL A 130 1 6 HELIX 8 AA8 THR A 144 GLU A 146 5 3 HELIX 9 AA9 CYS A 159 LYS A 179 1 21 HELIX 10 AB1 VAL A 180 MET A 190 1 11 HELIX 11 AB2 GLU A 192 HIS A 215 1 24 HELIX 12 AB3 GLN A 216 VAL A 221 1 6 HELIX 13 AB4 ASN A 222 VAL A 229 1 8 HELIX 14 AB5 VAL A 229 SER A 235 1 7 HELIX 15 AB6 ASN A 240 SER A 244 5 5 HELIX 16 AB7 SER A 263 GLN A 266 5 4 HELIX 17 AB8 SER A 267 LEU A 277 1 11 HELIX 18 AB9 GLY A 286 MET A 295 1 10 HELIX 19 AC1 ARG A 296 MET A 299 5 4 HELIX 20 AC2 PRO A 300 SER A 312 1 13 HELIX 21 AC3 SER A 315 SER A 322 1 8 HELIX 22 AC4 ASP A 325 ILE A 354 1 30 HELIX 23 AC5 ILE A 354 GLN A 360 1 7 HELIX 24 AC6 ASP A 383 LYS A 397 1 15 HELIX 25 AC7 PRO B 33 PHE B 35 5 3 HELIX 26 AC8 TYR B 36 HIS B 45 1 10 HELIX 27 AC9 HIS B 45 SER B 52 1 8 HELIX 28 AD1 GLN B 54 LYS B 61 1 8 HELIX 29 AD2 ASP B 72 GLY B 93 1 22 HELIX 30 AD3 PRO B 104 GLU B 119 1 16 HELIX 31 AD4 VAL B 125 VAL B 130 1 6 HELIX 32 AD5 THR B 144 GLU B 146 5 3 HELIX 33 AD6 CYS B 159 LYS B 179 1 21 HELIX 34 AD7 VAL B 180 MET B 190 1 11 HELIX 35 AD8 GLU B 192 HIS B 215 1 24 HELIX 36 AD9 GLN B 216 VAL B 221 1 6 HELIX 37 AE1 ASN B 222 VAL B 229 1 8 HELIX 38 AE2 VAL B 229 SER B 235 1 7 HELIX 39 AE3 ASN B 240 SER B 244 5 5 HELIX 40 AE4 SER B 263 GLN B 266 5 4 HELIX 41 AE5 SER B 267 LEU B 277 1 11 HELIX 42 AE6 GLY B 286 MET B 295 1 10 HELIX 43 AE7 ARG B 296 MET B 299 5 4 HELIX 44 AE8 PRO B 300 SER B 312 1 13 HELIX 45 AE9 SER B 315 LYS B 323 1 9 HELIX 46 AF1 ASP B 325 ILE B 354 1 30 HELIX 47 AF2 ILE B 354 SER B 359 1 6 HELIX 48 AF3 LEU B 384 LYS B 397 1 14 SHEET 1 AA1 2 VAL A 102 LEU A 103 0 SHEET 2 AA1 2 VAL A 248 TYR A 249 1 O VAL A 248 N LEU A 103 SHEET 1 AA2 2 LYS A 135 LYS A 136 0 SHEET 2 AA2 2 MET A 148 ASP A 149 -1 O ASP A 149 N LYS A 135 SHEET 1 AA3 2 VAL B 102 LEU B 103 0 SHEET 2 AA3 2 VAL B 248 TYR B 249 1 O VAL B 248 N LEU B 103 SHEET 1 AA4 2 LYS B 135 LYS B 136 0 SHEET 2 AA4 2 MET B 148 ASP B 149 -1 O ASP B 149 N LYS B 135 SSBOND 1 CYS A 308 CYS B 308 1555 1555 2.04 LINK NE2 HIS A 346 FE HEM A 501 1555 1555 2.00 LINK NE2 HIS B 346 FE HEM B 501 1555 1555 2.09 SITE 1 AC1 21 PHE A 163 SER A 167 PHE A 214 PHE A 226 SITE 2 AC1 21 ALA A 264 PHE A 270 ARG A 343 HIS A 346 SITE 3 AC1 21 ILE A 349 TYR A 353 ILE A 354 THR A 379 SITE 4 AC1 21 GLY A 380 GLY A 381 THR A 382 LEU A 384 SITE 5 AC1 21 VAL A 391 AOJ A 502 HOH A 601 HOH A 646 SITE 6 AC1 21 HOH A 673 SITE 1 AC2 12 TYR A 126 VAL A 130 PHE A 163 SER A 167 SITE 2 AC2 12 PHE A 226 LEU A 234 GLY A 262 SER A 263 SITE 3 AC2 12 ALA A 264 GLY A 378 THR A 379 HEM A 501 SITE 1 AC3 23 TYR B 126 PHE B 163 VAL B 170 PHE B 214 SITE 2 AC3 23 PHE B 226 ALA B 264 PHE B 270 ARG B 343 SITE 3 AC3 23 HIS B 346 ILE B 349 VAL B 350 TYR B 353 SITE 4 AC3 23 ILE B 354 THR B 379 GLY B 380 GLY B 381 SITE 5 AC3 23 THR B 382 PHE B 387 LEU B 388 VAL B 391 SITE 6 AC3 23 AOJ B 502 HOH B 610 HOH B 635 SITE 1 AC4 12 TYR B 126 VAL B 130 PHE B 163 SER B 167 SITE 2 AC4 12 PHE B 226 LEU B 234 GLY B 262 SER B 263 SITE 3 AC4 12 ALA B 264 GLY B 378 THR B 379 HEM B 501 CRYST1 85.200 91.990 131.120 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011737 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010871 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007627 0.00000